Trial Profile
Effect of C-peptide on diabetic peripheral neuropathy, a 6 months randomized double-blind, placebo controlled, dose-finding, multicenter study, with parallel groups
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs C-peptide (Primary)
- Indications Diabetic neuropathies
- Focus Therapeutic Use
- Sponsors Creative Peptides
- 14 Mar 2007 New trial record.